IVRA
Live / Applied — Statement of use — non-final action mailed (as of 23 Mar 2026)
What this means for you
Not registered yet, but its 12 Sept 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98747709
- Mark type
- Stylized text
- Filed
- 12 Sept 2024
- Published for opposition
- 08 Apr 2025
- Attorney of record
- Jessica G. Kraver
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparation for palliative treatment of patients with multiple myeloma
Owner
- Apotex Inc., Toronto, Ontario, CA
- Apotex Inc., Toronto, Ontario, CA
Prosecution history
- 23 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 23 Mar 2026 — NON-FINAL ACTION E-MAILED
- 23 Mar 2026 — SU - NON-FINAL ACTION - WRITTEN
- 08 Jan 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 02 Jul 2025 — USE AMENDMENT FILED
- 07 Jan 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Jul 2025 — TEAS STATEMENT OF USE RECEIVED
- 02 Jul 2025 — SOU EXTENSION 1 GRANTED
- 02 Jul 2025 — SOU EXTENSION 1 FILED
- 02 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Jun 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 08 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Apr 2025 — PUBLISHED FOR OPPOSITION
- 02 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED